- Global Operation
- Contract Manufacturing
Etoricoxib is a Non-Steroidal Anti-Inflammatory Drug (NSAID) that exhibits anti-inflammatory & analgesic activities. It is a potent, orally active, highly selective second generation cyclooxygenase-2 (COX-2) inhibitor. COX-2 has been shown to be primarily responsible for the synthesis of prostanoid mediators of pain & inflammation. Selective inhibition of COX-2 by Etoricoxib decreases these clinical signs and symptoms with decreased GI toxicity and without effects on platelet function.
Etoricoxib is indicated to relief of pain and inflammation in -
• Symptomatic treatment of the signs and symptoms of osteoarthritis, rheumatoid arthritis & ankylosing spondylitis
• Treatment of acute gouty arthritis
• Treatment of acute pain including dental pain & primary dysmenorrhea
Danilo Tablet 90 mg: Each box contains 3x10’s tablets in Alu-PVDC blister pack.
Danilo Tablet 120 mg: Each box contains 3x10’s tablets in Alu-PVDC blister pack.